Call Us      +44 (0)20 70961222

Clinical Operations


23rd May 2018 | Hotel Sofitel, Munich, Germany


Redefining the art of business networking, Proventa International’s Clinical Operations strategy meeting offers a more comprehensive experience than regular clinical operation conferences. Our unique format gathers c-level executives from Europe and all over the globe to discuss shared key challenges on clinical operations. Our team pre-qualifies all attendees so you can be sure you only meet decision makers of large and emerging pharma, biotech and biopharma companies.

Aside from the networking opportunities you get from clinical operation summits in Germany, Proventa International also lets you explore clinical operation trends and topics like risk-based monitoring, eTMF, clinical data management and more with experienced professionals. Interactive and insightful, our executive roundtable discussions allow each delegate to raise questions relevant to their organization and share best practices in the industry.

Our Clinical Operations Strategy Meeting also offers one-to-one business meetings where you choose which clinical operation expert you want to meet, discuss strategic priorities with and build a partnership with to help you achieve short to long-term business goals. Need strategies on efficient clinical outsourcing? Hit us up so we can schedule you with a subject matter expert!

Business leaders who will benefit from attending include CXOs, EVPs, SVPs, VPs, Executive Directors, Directors and Global Heads responsible for:

Clinical Operations

Safety Data Management

Data Sciences

Clinical Trial Management

Clinical Outsourcing

Data Acquisition Technology & Integrations

Patient Recruitment

Pharmacology Scientific Operations


Clinical Informatics and Innovation

The Clinical Operations Strategy Meeting Europe is happening on May 23, 2018 at Sofitel Munich in Germany. Download full agenda here.

To see other strategy meetings near your area, click here

Yuri Martina

Yuri Martina

Vice President Clinical Operations


Christian Milliet

Christian Milliet

Global Head Clinical Operations

Vifor Pharma


Hindrik Robbe

Senior Director Medical Affairs EMEA, Cardiac Arrhythmias & Heart Failure


Sezcan Ozturk

Sezcan Ozturk

Clinical Operations Director

Novo Nordisk

Gerard Barron

Gerard Barron

Director, Clinical Operations


Dikla Sharon

Dikla Sharon

Director, Clinical Programs Team Lead


Savitha Ram Moorthi

Savitha Ram Moorthi

Director, Clinical Quality and Pharmacovigilance

Novo Nordisk

Martin Hausten

Martin Hausten

Head of Global Document Quality Center

Boehringer Ingelheim

Interactive Roundtable Discussions

Attendees can proactively share and ask questions to their peers about the success of their work in an informal setting.

one to one copy
Director level one-to-one meetings

We provide opportunities to engage with one another in our strategy meeting in a series of pre-arranged business meetings by interacting face to face.

Tailor-fit and Personalized Agenda

Being able to experience different sessions is what makes our event unique that’s why our attendees can personalize and select sessions they want to participate in.

netwkorking copy
Networking Opportunities

Several networking opportunities are in store for attendees to connect and build new relationships with their peers through luncheons, cocktails and informal introductions.

Thank you for reaching Proventa International

One of our executives will contact you within 24 hours



***The information you provided in this website is confidential and the company will strictly forbidden to share any part of these information with any third party without a written consent of the sender.


If you are an exciting start-up trying to get your innovation in front global heads from the leading Pharmaceutical companies, or a mature market-leading conglomerate with legacy solutions trying to stay one step ahead of the competition – we are here to help!


Clinical Operations Strategy Meeting Europe 2016

John Apathy, Vice President, R&D informatics, Celgene

Lars Branden, Senor Director,Informatics R&D Division, Retro Screen Virology Ltd.

Dominic Clark , Industry Programme Manager, EMBL-EBI

Yike Guo, Director Data Science Institude, Imperial College London

John Wise, Executive Director, Pistoia Alliance

Abel Ureta-Vida, CEO, Eagle Genomics

Alexander Scheer, Deputy Head of Research, Pierre Fabre

Jerome Wojcik , CEO, Quartz Bio

Oleksandr Otava, Head Of Scientific IT, Affiris AG

Sowmyanarayan Srinivasan, Director R&D Practise,Global Delivery Leader Discovery

Yaron Turpaz

Chief Information Officer

Its nice because they basically allowed people to engaged to discussions and questions. Academic and industry is very nice and informative

Ivan John Clement

Data Scientist - R&D

Its good because you really get the people to talk. They are willing to share their knowledge, the juniors are very eager to learn.

Raghuraman Gopal

Manager Quality Assurance

The format is the beginning of breakthrough and integration, the level of delegates is very good and excellent, they learn a lot.

Dadabhai Singh

Founder & President

The kind of interaction is very interactive

Steve Rozen

Director & Professor

Because of diversity we really districts the points and all. People are very diversity and thoughtful in a round table.




Bayerstraße 12, 80335 München, Germany


+49 89 599480



Yuri Martina

Vice President Clinical Operations, Grunenthal


Dr. Yuri Martina was appointed Vice President Global Clinical Operations for Grunenthal in September 2017. Dr. Martina has more than 18 years experience in the Pharmaceutical Industry dedicated to Clinical Operations and Project Management. Dr. Martina lived in different countries (USA, Canada, Austria, Italy, UK, China and Japan) and worked for different international and global companies (Novartis, Merck-Serono, Roche, Baxter, Parexel, Shionogi).
Dr. Martina holds a Ph.D. in Genetics and Molecular Biology and a Degree in Economics from the prestigious University “La Sapienza” in Rome. He also holds an M.B.A. degree from the Open University and he is a PMP© certified Project Manager.
Dr. Martina’s interest has been recently focused on the development of Global Clinical Operations Excellence in order to reduce costs and timelines for drug development by identifying and balancing the right mixture of internal efficient structures and outsourcing with the support of proper Project Management.


Hindrik Robbe

Senior Director Medical Affairs EMEA, Cardiac Arrhythmias
& Heart Failure , Abbott

Hindrik Robbe is Director of Clinical Research, EMEA, for Abbott and came to Abbott through the acquisition of St Jude Medical by Abbott early 2017.

Hindrik has more than 30 years of experience in clinical research. He started his career at the Institute for Human Psychopharmacology at the University of Maastricht where he obtained his PhD thesis in Health Sciences.

Since 1996, Hindrik is active in the medical device industry. He worked fourteen years at Medtronic where he held multiple positions with increasing responsibility in clinical research and outcomes studies. In 2010 he joined St Jude Medical as Vice President Clinical Affairs, Health Economics & Reimbursement, for the EMEAC region.


Christian Milliet

Global Head Clinical Operations, Vifor Pharma

Christian Milliet has 20 years of international experience in the pharmaceutical industry. He is currently Global Head Clinical Operations at Vifor Pharma, based in Switzerland. Previously, he worked for Novartis, Serono and Covance. Christian graduated from Webster University in St. Louis, USA.


Martin Hausten

Martin Hausten

Head of Global Document Quality Center

Boehringer Ingelheim


Martin Hausten is working for Boehringer Ingelheim (Germany) since 2004. In March 2016 he has taken over the role as Head of Global Document Quality Centre responsible for the harmonization and standardization of global trial master file processes and leading a team of internationally working and highly skilled Global Document Specialists. Before that, Martin was holding positions within Quality Management and Computer System Validation. From 2013 to 2016 he was acting as Project Compliance Manager with main responsibility to establish quality and risk management principles into clinical development projects. Martin collected deep insight into Service Providers Quality Management Systems during his role as a GCP Auditor (2008-2013).



Savitha Ram Moorthi

Clinical Operations Director, International Operations, Novo Nordisk


Savitha Ram Moorthi is a Director Clinical Quality and Pharmacovigilance for International Operations in Novo Nordisk. Prior to that, she served as the Director Clinical Operations Europe in which she is responsible for the clinical operations functions within clinical medical regulatory in Europe. As a Senior Project Manager for EU Clinical Medical Regulatory (CMR) from 2003-2014, she accomplished a number of things. She was responsible for country allocation, tracking, coordinating and risk mitigating the European clinical trial performance in all critical trials and for driving productivity by providing global and regional benchmarks and transparency across Europe. Savitha completed her postgraduate certificate program in Pharmaceutical Medicine at the University of Basel. She is a pharmacist by training with Post graduate degrees in pharmaceutics and clinical pharmacology.


Sezcan Ozturk

Director, Clinical Quality and Pharmacovigilance,Novo Nordisk


Sezcan Ozturk is the Clinical Operations Director in Novo Nordisk, International Operations region (a region which consists of entire world except US and Canada) where part of his responsibilities are ensuring timely deliverables of the clinical trials, availability of adequate clinical resources and productivity of the clinical operation teams in his region.

He has more than 16 years of experience in clinical research area. He has been in several different roles within clinical operations, clinical project management, clinical quality and training during my career and in different companies such as Novo Nordisk, Roche Pharmaceuticals and a local CRO in Turkey.


Vifor Pharma

Dikla Sharon

Director, Clinical Programs Team Lead, Shire

Dikla Sharon is a clinical operations professional, experienced in planning and execution of global clinical studies phase I-IV and focused on rare diseases. She excels in drug development planning by incorporating ethical considerations, operational needs, and company business drivers. Her current role is Clinical Programs Team Lead, Hematology at Shire. She  joined the BioPharma division of Baxter in 2012 and worked through its spin-off to Baxalta and subsequent acquisition by Shire. Prior to joining Baxter, she held various positions within a CRO and served in the Israeli Defence Force as an officer in the Medical Corp.


Vifor Pharma

Christina Araujo-Tenreiro

Clinical Development Program Director, Ipsen

Christina Araujo-Tenreirois  am Director of Clinical Development Programs. She eighteen years of experience in the pharmaceutical industry, with a focus on Clinical Development and a therapeutic expertise spanning rom Cardiovascular Disease, Diabetes, Depression, Immuno-Oncology and more recently Neurosciences.

Prior to joining Ipsen, She assumed demanding responsibilities within Servier as Alliance Management Project Director, overseeing two partnerships (with Pfizer and Cellectis) in immuno-oncology.

Prior to that, She has been working 15 years within Clinical Operations. I got a broad experience on the management of international clinical trials in partnerships with internal and external partners (academic, local, middle and big size CROs) through a position as Director of International Clinical Study Management. Through these different positions she developed a strong leadership, organisational skills and positive team spirit looking to accomplish challenging missions.



Vifor Pharma

Gerard Barron

Director, Clinical Operations, MedImmune

Gerard Barron is a Director in the Respiratory, Inflammation and Autoimmunity (RIA) division of MedImmune’s Clinical Biologics Group with responsibility for strategic clinical operations on assigned programmes. Gerard has been with MedImmune for 9 years and has delivered a number of clinical trials across various RIA indications. Gerard’s current focus is on rare autoimmune and inflammatory diseases including a pioneering trial in Neuromyelitis optics.

Gerard has been in the pharmaceutical industry for approximately 20 years, previous employment includes small pharma Astex Therapeutics, GW Pharmaceuticals and Covance where he started his career in data management.



Pingping Ni

Head of Statistics, Mitsubishi Tanabe

Pingping Ni is a trained mathematician and statistician, educated in China and US. She worked as computer engineer in Chinese Academy of Sciences for a number of years before becoming a clinical statistician. Pingping has worked in Bayer (Berlex) and GSK in US and UK, and is now the Head of Statistics in Mitsubishi Tanabe Pharma Europe ltd. She is results oriented, passionate on incorporating new methods, technologies and ideas into drug with aim to improve efficiency and quality of decision making.


Franck Gressier

Head Clinical Quality Assurance, Pierre Fabre


Franck Gressier, Head R&D Clinical QA, Pierre Fabre, holds Master’s degrees in Biochemistry as well as in Pharmacology and Biology of Ageing. He began his career in 1995 at Sanofi Nutrition as an assistant of project manager. From 1996 to 2004, he held the position of Clinical Research Associate at Innovex, Quintiles and then in the French subsidiary of Boehringer Ingelheim before moving to Sanofi Pasteur from 2008 to 2015, as a Clinical Quality Manager where he had two one-year assignments at Sanofi Pasteur’s Asia (Singapore) subsidiary to ensure the development of Vaccines Clinical Quality Assurance Activities in the Asia/Pacific region. Moving to Pierre Fabre Lab, he is now Head of Clinical Quality Assurance Department.